Riyi Shi Selected Research

Multiple Sclerosis

1/2019	Coupling the Paternò-Büchi (PB) Reaction With Mass Spectrometry to Study Unsaturated Fatty Acids in Mouse Model of Multiple Sclerosis.
1/2018	Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis.
1/2017	Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.
6/2014	Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.
10/2013	New insights in the pathogenesis of multiple sclerosis--role of acrolein in neuronal and myelin damage.
5/2011	Acrolein induces myelin damage in mammalian spinal cord.
2/2011	Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons.
1/2011	Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riyi Shi Research Topics

Disease

40	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 01/2002
17	Wounds and Injuries (Trauma) 12/2022 - 03/2005
8	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 06/2004
8	Multiple Sclerosis 01/2019 - 01/2011
7	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2018
7	Neuralgia (Stump Neuralgia) 01/2018 - 03/2014
6	Hypersensitivity (Allergy) 07/2022 - 03/2014
5	Pain (Aches) 07/2021 - 03/2014
5	Demyelinating Diseases (Demyelinating Disease) 01/2016 - 10/2007
4	Inflammation (Inflammations) 10/2021 - 01/2011
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 08/2006
3	Nervous System Diseases (Neurological Disorders) 06/2020 - 03/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 10/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2011 - 12/2005
2	Contusions 04/2021 - 08/2017
2	Hyperalgesia 01/2018 - 08/2017
2	Neuroinflammatory Diseases 01/2017 - 03/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 06/2004
2	Shock 03/2016 - 10/2011
2	Gliosis 02/2016 - 03/2004
2	Hypertension (High Blood Pressure) 01/2010 - 07/2006
2	Necrosis 07/2006 - 12/2005
2	Ischemia 06/2006 - 01/2005
1	Cysts 07/2022
1	Neurobehavioral Manifestations 11/2021
1	Osteoarthritis 10/2021
1	AIDS-Related Complex (ARC) 10/2021
1	Blast Injuries 01/2021
1	Iron Deficiencies 11/2019
1	Iron Overload 11/2019
1	Parkinsonian Disorders (Parkinsonism) 11/2019
1	Synucleinopathies 01/2019
1	Neoplasms (Cancer) 10/2017
1	Obesity 10/2017
1	Burns 10/2017
1	Pathologic Processes 01/2017

Drug/Important Bio-Agent (IBA)

35	Acrolein (Aqualin)IBA 12/2022 - 12/2003
10	AldehydesIBA 07/2022 - 12/2009
9	Hydralazine (Apresoline)FDA LinkGeneric 01/2022 - 07/2006
9	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2013 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2004
5	Potassium Channels (Potassium Channel)IBA 02/2012 - 02/2009
5	PolymersIBA 05/2010 - 01/2002
4	AnkyrinsIBA 01/2021 - 12/2015
4	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2005
4	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 01/2018 - 02/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 10/2002
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
3	Explosive Agents (Explosives)IBA 01/2021 - 10/2011
3	Glutamic Acid (Glutamate)FDA Link 06/2020 - 01/2019
3	LipidsIBA 01/2019 - 12/2009
3	TRPA1 Cation ChannelIBA 08/2017 - 03/2014
3	CalciumIBA 02/2012 - 10/2007
3	4-Aminopyridine (4 Aminopyridine)FDA Link 02/2011 - 02/2006
3	Free RadicalsIBA 12/2009 - 10/2002
2	SynucleinsIBA 11/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2019
2	Dimercaprol (B.A.L.)FDA Link 01/2021 - 01/2017
2	Sucrose (Saccharose)IBA 01/2019 - 10/2011
2	CarbonIBA 01/2019 - 03/2004
2	Phenelzine (Nardil)FDA Link 01/2018 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 01/2018 - 03/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2015
2	EmulsionsIBA 01/2017 - 01/2016
2	Superoxides (Superoxide)IBA 11/2008 - 02/2008
1	Conditioned Culture MediaIBA 12/2022
1	Mitochondrial Aldehyde DehydrogenaseIBA 07/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	IsoflavonesIBA 11/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2021
1	BuffersIBA 07/2021
1	Oxyhemoglobins (Oxyhemoglobin)IBA 04/2021
1	salicylhydroxamic acid (SHAM)IBA 04/2021
1	DesminIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	Clioquinol (Vioform)FDA Link 01/2020
1	IronIBA 11/2019
1	Food Additives (Food Additive)IBA 11/2019
1	ferric citrateIBA 11/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	alpha-SynucleinIBA 01/2018
1	NeurotoxinsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	SmokeIBA 08/2017
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2017
1	Pertussis ToxinIBA 01/2017
1	Evans Blue (Blue, Evans)FDA Link 02/2016
1	Glial Fibrillary Acidic ProteinIBA 02/2016
1	SilverIBA 02/2016
1	Coloring Agents (Dyes)IBA 02/2016
1	fluoro jadeIBA 02/2016
1	Hemostatics (Antihemorrhagics)IBA 01/2016

Therapy/Procedure

8	Therapeutics 11/2021 - 02/2008
2	Intraperitoneal Injections 01/2017 - 01/2017
1	Microelectrodes 12/2022
1	Oral Administration 11/2019
1	Protective Devices (Safety Device) 01/2018
1	Subcutaneous Injections 01/2017